• Home
  • Technology
  • Press & Media
  • Careers
  • Contact

A better way to diagnose.

Phoresa is developing high-accuracy pregnancy-style tests for infectious diseases. Our tests will provide better patient management, lower healthcare costs, and help reduce the spread and complication of disease.

Healthcare Impact

Picture

Immediate Patient Care

Because clinics run our tests in the office, patients no longer have to wait for test results from the lab—they can receive a diagnosis and treatment during their initial visit.
Picture

Reduced Costs

With our tests, everyone benefits. Patients save by paying a fraction of the cost of a lab-based test. Clinics profit from running tests in-house. And insurance payers see their per-patient costs drop due to improved patient outcomes.
Picture

Improved Public Health

With more clinics offering quick, affordable, and reliable screening, more patients can be tested and get the treatment they need—when they need it. This means reduced risk of patient complications, increased prevention efforts, and improved treatment compliance.

Our Technology

Our tests have all the advantages of traditional lateral flow assays: low cost, rapid results, and the ability to provide results at the clinic. But we go one step further—our tests improve sensitivity up to 100x so that clinicians can make confident diagnoses without the need for laboratory resources.
Picture

Partners and Support

Picture
Picture
Picture
Picture
Picture
Picture

The Team

element_settings.Image_30621876.default
Charlie Corredor, PhD
​
Co-Founder, CEO
Picture

Mark D. Borysiak, PhD

​Co-Founder, CTO

Picture

Jonathan Posner, PhD

​Co-Founder, Scientific Director

Picture

 Matthew Thompson, MD
​

Co-Founder, Medical Director

Picture
© 2017 Phoresa, Inc. All rights reserved.
  • Home
  • Technology
  • Press & Media
  • Careers
  • Contact